Get the app
NSE › Healthcare

Themis Medicare Limited (THEMISMED)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹106.53+0.15%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
₹88 cr
Revenue YoY
-9.9%
Net profit
₹25 cr
Net margin
28.0%

Key statistics

Market cap
₹991 cr
P/E
24.6
Forward P/E
0.0
P/B
2.83
Book value
₹43.06
EPS (TTM)
₹4.33
52-week high
₹140.03
52-week low
₹64.69
50-day MA
₹117.34
200-day MA
₹100.38
Beta
0.55

Shareholding

Promoters
67.11%

Largest named holders

HolderStake
Anuj Anantrai Sheth3.80%
Zafar Ahmadullah2.11%
Za Capital Services India Private Ltd1.53%

Recent filings & reports

DocumentDate
Investor presentation · Q1 FY27
THEMIS MEDICARE LIMITED – Q1 FY27 INVESTOR SUMMARY HEADLINE NUMBERS • Consolidated Revenue Q1 FY27: ₹86.96 crore (down 10.9% YoY from ₹97.58 crore i
2026-08-13
Quarterly results · Q1 FY27
THEMIS MEDICARE LIMITED – BOARD MEETING SUMMARY (13 AUGUST 2026) HEADLINE NUMBERS • Quarter ended 30 June 2026: Un-audited standalone and consolidat
2026-08-13
Investor presentation · Q4 FY26
THEMIS MEDICARE LIMITED – Q4 & FY26 INVESTOR SUMMARY HEADLINE NUMBERS • FY26 Consolidated Revenue: ₹342.2 crore (down 15.6% YoY from ₹405.5 crore in
2026-05-28
Quarterly results · Q4 FY26
THEMIS MEDICARE LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • FY 2025-26 Revenue from Operations (Net): Rs. 34,223.55 lakhs, down 15.6% from Rs. 40,
2026-05-28
Quarterly results · Q3 FY26
THEMIS MEDICARE LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Q3 FY2025-26 Standalone Revenue: Rs 9,013.32 lakhs (vs Rs 9,380.63 lakhs in Q3 FY2024-
2026-02-13
Investor presentation
THEMIS MEDICARE LIMITED - Q3 & 9M FY26 INVESTOR SUMMARY HEADLINE NUMBERS • Q3 FY26 Revenue: ₹90.13 crore (down 3.9% YoY from ₹93.81 crore in Q3 FY25
2026-02-13
Investor presentation · Q2 FY26
THEMIS MEDICARE LIMITED – Q2 & H1 FY26 SUMMARY HEADLINE NUMBERS • Q2 FY26 Revenue: ₹78 crore (down 33.3% YoY from ₹117 crore in Q2 FY25) • Q2 FY26 P
2025-11-13
Quarterly results · Q2 FY26
THEMIS MEDICARE LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q2 FY2025-26 Revenue (Standalone): INR 7,799.41 lakhs (down 33% YoY from INR 11,700.9
2025-11-13

Readable in the app.

Corporate actions

ActionDetailDate
Dividend₹0.50 / share
ex-date Sep 23, 2026
2026-09-23

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Themis Medicare Limited — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-10-18.